Author
Listed:
- Kossay Zaoui
(Centre de recherche du Centre hospitalier de l’Université de Montréal (CRCHUM)
Institut du cancer de Montréal)
- Zied Boudhraa
(Centre de recherche du Centre hospitalier de l’Université de Montréal (CRCHUM)
Institut du cancer de Montréal)
- Paul Khalifé
(Centre de recherche du Centre hospitalier de l’Université de Montréal (CRCHUM)
Institut du cancer de Montréal)
- Euridice Carmona
(Centre de recherche du Centre hospitalier de l’Université de Montréal (CRCHUM)
Institut du cancer de Montréal)
- Diane Provencher
(Centre de recherche du Centre hospitalier de l’Université de Montréal (CRCHUM)
Institut du cancer de Montréal
Université de Montréal)
- Anne-Marie Mes-Masson
(Centre de recherche du Centre hospitalier de l’Université de Montréal (CRCHUM)
Institut du cancer de Montréal
Université de Montréal)
Abstract
Ran is a nucleocytoplasmic shuttle protein that is involved in cell cycle regulation, nuclear-cytoplasmic transport, and cell transformation. Ran plays an important role in cancer cell survival and cancer progression. Here, we show that, in addition to the nucleocytoplasmic localization of Ran, this GTPase is specifically associated with the plasma membrane/ruffles of ovarian cancer cells. Ran depletion has a drastic effect on RhoA stability and inhibits RhoA localization to the plasma membrane/ruffles and RhoA activity. We further demonstrate that the DEDDDL domain of Ran is required for the interaction with serine 188 of RhoA, which prevents RhoA degradation by the proteasome pathway. Moreover, the knockdown of Ran leads to a reduction of ovarian cancer cell invasion by impairing RhoA signalling. Our findings provide advanced insights into the mode of action of the Ran-RhoA signalling axis and may represent a potential therapeutic avenue for drug development to prevent ovarian tumour metastasis.
Suggested Citation
Kossay Zaoui & Zied Boudhraa & Paul Khalifé & Euridice Carmona & Diane Provencher & Anne-Marie Mes-Masson, 2019.
"Ran promotes membrane targeting and stabilization of RhoA to orchestrate ovarian cancer cell invasion,"
Nature Communications, Nature, vol. 10(1), pages 1-12, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-10570-w
DOI: 10.1038/s41467-019-10570-w
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-10570-w. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.